Physician profile
John J Sullivan
NPI 1053340372
$3,935.64
in general payments reported to CMS, 2019-2025
25 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,671 · 2020: $181 · 2021: $283 · 2022: $255 · 2023: $32.40 · 2024: $206 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,122.14 | 2019 | |
| Abbvie INC. | $493.10 | 2019-2024 | Liletta |
| Astellas Pharma US INC | $226.78 | 2020-2025 | Veozah |
| Allergan, INC. | $165.61 | 2019-2020 | |
| Distalmotion US | $159.86 | 2025 | Dexter L6 Robot |
| Therapeuticsmd, INC. | $143.35 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $96.72 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Ferring Pharmaceuticals INC. | $63.07 | 2019 | |
| Hologic Sales and Service, LLC | $61.86 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $52.55 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $43.23 | 2019 | |
| Duchesnay USA Incorporated | $38.90 | 2019-2020 | |
| Exeltis, USA INC. | $38.76 | 2021-2022 | |
| Evofem Biosciences, INC. | $33.58 | 2021 | |
| Mayne Pharma Commercial LLC | $29.87 | 2022-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.22 | 2021-2022 | |
| Lupin INC. | $24.06 | 2019 | |
| Coopersurgical, INC. | $21.87 | 2024 | Paragard T 380a |
| Organon LLC | $15.68 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2022 | |
| Olympus America INC. | $14.28 | 2019 | |
| Celltrion USA INC. | $13.86 | 2025 | Vegzelma |
| Takeda Pharmaceuticals U.S.A., INC. | $12.17 | 2019 | |
| Minerva Surgical, INC | $12.14 | 2022 | |
| Meditrina | $11.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.